Rationale for off-label treatments use in primary progressive multiple sclerosis: A review of the literature - Archive ouverte HAL
Article Dans Une Revue Revue Neurologique Année : 2022

Rationale for off-label treatments use in primary progressive multiple sclerosis: A review of the literature

T. Chedid
  • Fonction : Auteur
Xavier Moisset

Dates et versions

hal-04721450 , version 1 (04-10-2024)

Identifiants

Citer

T. Chedid, Xavier Moisset, P. Clavelou. Rationale for off-label treatments use in primary progressive multiple sclerosis: A review of the literature. Revue Neurologique, 2022, 178 (9), pp.932-938. ⟨10.1016/j.neurol.2022.02.461⟩. ⟨hal-04721450⟩

Collections

PRES_CLERMONT ND
0 Consultations
0 Téléchargements

Altmetric

Partager

More